DiaSorin S.p.A (DIA) - Product Pipeline Analysis, 2018 Update

DiaSorin S.p.A (DIA) - Product Pipeline Analysis, 2018 Update


  • Products Id :- GDME1679PD
  • |
  • Pages: 107
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

DiaSorin S.p.A. (DiaSorin) is a medical diagnostics company that develops, manufactures and markets in vitro diagnostics reagent kits and systems. The company develops reagent kits based on Radioimmunometry (RIA), Enzyme Linked Immunosorbent Assays (ELISA) and Chemiluminescence (CLIA) techniques, to enable automatic diagnostic investigation. The company's products find application in the diagnosis of infectious diseases, bone and mineral disorders, endocrinology, hypertension, oncology, gastrointestinal infections, autoimmune disorders, and neurological and cardiac diseases. DiaSorin markets its products through direct sales force and distributors. It has operations in North America, South America, South Africa, EMEA and Asia. DiaSorin is headquartered at Saluggia, Piemonte, Italy.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company DiaSorin S.p.A

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 6

List of Figures 8

DiaSorin S.p.A Company Overview 9

DiaSorin S.p.A Company Snapshot 9

DiaSorin S.p.A Pipeline Products and Ongoing Clinical Trials Overview 9

DiaSorin S.p.A-Pipeline Analysis Overview 13

Business Description 13

DiaSorin S.p.A-Key Facts 13

DiaSorin S.p.A-Major Products and Services 14

DiaSorin S.p.A Pipeline Products by Development Stage 15

DiaSorin S.p.A Ongoing Clinical Trials by Trial Status 19

DiaSorin S.p.A Pipeline Products Overview 21

BCR-ABL ABL Assay 21

BCR-ABL ABL Assay Product Overview 21

BCR-ABL P190 + ABL Assay 22

BCR-ABL P190 + ABL Assay Product Overview 22

BCR-ABL v1.5 Assay 23

BCR-ABL v1.5 Assay Product Overview 23

C-Kit 816 Assay 24

C-Kit 816 Assay Product Overview 24

C-Kit 822 Assay 25

C-Kit 822 Assay Product Overview 25

Diagnostic Assay-Atypical Pneumonia 26

Diagnostic Assay-Atypical Pneumonia Product Overview 26

Diagnostic Assay-Chronic Kidney Disease 27

Diagnostic Assay-Chronic Kidney Disease Product Overview 27

Diagnostic Assay-Enteric Infection 28

Diagnostic Assay-Enteric Infection Product Overview 28

Diagnostic Assay-Fecal Occult Blood Assay 29

Diagnostic Assay-Fecal Occult Blood Assay Product Overview 29

Diagnostic Assay-GI Inflammation 30

Diagnostic Assay-GI Inflammation Product Overview 30

Diagnostic Assay-Group B Streptococcus Infection 31

Diagnostic Assay-Group B Streptococcus Infection Product Overview 31

Diagnostic Assay-HBsAg High Throughput 32

Diagnostic Assay-HBsAg High Throughput Product Overview 32

Diagnostic Assay-HCV II 33

Diagnostic Assay-HCV II Product Overview 33

Diagnostic Assay-HSV M + cntr 34

Diagnostic Assay-HSV M + cntr Product Overview 34

Diagnostic Assay-Lactoferrin Assay 35

Diagnostic Assay-Lactoferrin Assay Product Overview 35

Diagnostic Assay-Lipase Assay 36

Diagnostic Assay-Lipase Assay Product Overview 36

Diagnostic Assay-Mycoplasma Genitalium Infection 37

Diagnostic Assay-Mycoplasma Genitalium Infection Product Overview 37

Diagnostic Assay-Streptococcus Pneumonia 38

Diagnostic Assay-Streptococcus Pneumonia Product Overview 38

Diagnostic Assay-Vaginosis 39

Diagnostic Assay-Vaginosis Product Overview 39

Diagnostic Assay-Vector Borne Diseases 40

Diagnostic Assay-Vector Borne Diseases Product Overview 40

Estradiol II Assay 41

Estradiol II Assay Product Overview 41

H.Influenza B Assay 42

H.Influenza B Assay Product Overview 42

Human Herpes Virus 6 IgG EIA Assay 43

Human Herpes Virus 6 IgG EIA Assay Product Overview 43

Human Herpes Virus 8 IgG IFA Assay 44

Human Herpes Virus 8 IgG IFA Assay Product Overview 44

Hyperphosphate-High Bone Turnover Assay 45

Hyperphosphate-High Bone Turnover Assay Product Overview 45

LAMP CBF-MYH D Assay 46

LAMP CBF-MYH D Assay Product Overview 46

LAMP CBF-MYH E Assay 47

LAMP CBF-MYH E Assay Product Overview 47

LAMP VCA IgA Assay 48

LAMP VCA IgA Assay Product Overview 48

LIAISON-Anti-HDV Assay 49

LIAISON-Anti-HDV Assay Product Overview 49

LIAISON-Chlamydia P. IgA Assay 50

LIAISON-Chlamydia P. IgA Assay Product Overview 50

LIAISON-Chlamydia P. IgG Assay 51

LIAISON-Chlamydia P. IgG Assay Product Overview 51

LIAISON-High Sclerostin Assay 52

LIAISON-High Sclerostin Assay Product Overview 52

LIAISON-Hyperphosphate Low Bone Turnover Assay 53

LIAISON-Hyperphosphate Low Bone Turnover Assay Product Overview 53

LIAISON-Tg Gen II Assay 54

LIAISON-Tg Gen II Assay Product Overview 54

LIAISON IAM-Acute Lymphoblastic Leukemia Test 55

LIAISON IAM-Acute Lymphoblastic Leukemia Test Product Overview 55

LIAISON IAM-Acute Promyelocytic Leukemia Test 56

LIAISON IAM-Acute Promyelocytic Leukemia Test Product Overview 56

LIAISON IAM-EBV Assay 57

LIAISON IAM-EBV Assay Product Overview 57

LIAISON IAM-Myeloproliferative Neoplasm Assay 58

LIAISON IAM-Myeloproliferative Neoplasm Assay Product Overview 58

LIAISON XL-Chlamydia Pneumoniae Assay 59

LIAISON XL-Chlamydia Pneumoniae Assay Product Overview 59

LIAISON XL-H. Pylori Ag Assay 60

LIAISON XL-H. Pylori Ag Assay Product Overview 60

LIAISON XL-H. Pylori Ag Assay Clinical Trial 61

LIAISON XL-Hepatitis A Assay 62

LIAISON XL-Hepatitis A Assay Product Overview 62

LIAISON XL-Hepatitis B Assay 63

LIAISON XL-Hepatitis B Assay Product Overview 63

LIAISON XL-Hepatitis C Assay 64

LIAISON XL-Hepatitis C Assay Product Overview 64

Liaison XL-HIV 65

Liaison XL-HIV Product Overview 65

LIAISON XL-Parvovirus B19 Test 66

LIAISON XL-Parvovirus B19 Test Product Overview 66

LIAISON XL-Sclerostin Assay 67

LIAISON XL-Sclerostin Assay Product Overview 67

LIAISON XL Zika Capture IgM Assay 68

LIAISON XL Zika Capture IgM Assay Product Overview 68

LIAISON XL- Procalcitonin Assay 69

LIAISON XL- Procalcitonin Assay Product Overview 69

LIAISON XS 70

LIAISON XS Product Overview 70

Neisseria meningitidis Assay 71

Neisseria meningitidis Assay Product Overview 71

Parvovirus B19 IFA Assay 72

Parvovirus B19 IFA Assay Product Overview 72

PML-RAR Alpha BCR2 Assay 73

PML-RAR Alpha BCR2 Assay Product Overview 73

PML-RAR1 + ABL Assay 74

PML-RAR1 + ABL Assay Product Overview 74

PML-RAR2 + ABL Assay 75

PML-RAR2 + ABL Assay Product Overview 75

PML-RAR3 + ABL Assay 76

PML-RAR3 + ABL Assay Product Overview 76

Progesterone II Assay 77

Progesterone II Assay Product Overview 77

Quant ABL Assay 78

Quant ABL Assay Product Overview 78

Quant BCR-ABL p210 Assay 79

Quant BCR-ABL p210 Assay Product Overview 79

Reagent ASRs-Gastro-intestinal Infections 80

Reagent ASRs-Gastro-intestinal Infections Product Overview 80

Reagent ASRs-Genetic Disorders 81

Reagent ASRs-Genetic Disorders Product Overview 81

Reagent ASRs-Immuno-Compromised Disorders 82

Reagent ASRs-Immuno-Compromised Disorders Product Overview 82

Reagent ASRs-Infectious Disease 83

Reagent ASRs-Infectious Disease Product Overview 83

Reagent ASRs-Respiratory Disease 84

Reagent ASRs-Respiratory Disease Product Overview 84

Reagent ASRs-Vector-Borne Disease 85

Reagent ASRs-Vector-Borne Disease Product Overview 85

Respiratory Virus Panel 86

Respiratory Virus Panel Product Overview 86

Simplexa Bordetella Direct 87

Simplexa Bordetella Direct Product Overview 87

Simplexa Enterovirus Direct 88

Simplexa Enterovirus Direct Product Overview 88

Simplexa MRSA Direct 89

Simplexa MRSA Direct Product Overview 89

DiaSorin S.p.A-Key Competitors 90

DiaSorin S.p.A-Key Employees 91

DiaSorin S.p.A-Key Employee Biographies 92

DiaSorin S.p.A-Locations And Subsidiaries 93

Head Office 93

Other Locations & Subsidiaries 93

Recent Developments 95

DiaSorin S.p.A, Recent Developments 95

May 08, 2018: The Diasorin Group Reports Growth in Revenues and Profitability in the First Quarter 2018 95

Apr 05, 2018: Diasorin Receives FDA Clearance For LIAISON BRAHMS PCT II GEN Assay To Detect Severe Bacterial Infections (Sepsis) 97

Mar 28, 2018: DiaSorin Earns FDA Clearance Extending Sample Claims For HSV 1 & 2 Test 97

Dec 12, 2017: Diasorin Launches A New Simplexa Bordetella Direct Molecular Test 98

Nov 09, 2017: Growth In Revenues And Net Profit In Q3 2017. Strong Free Cash Flow Generation. 2017 Guidance Confirmed 98

Sep 26, 2017: DiaSorin Molecular Introduces Two Primer Pair Reagents for Streptococcus 99

Sep 21, 2017: Diasorin Earned CE-Mark Extending Sample Claims For Diasorin Moleculars Simplexa HSV 1 & 2 Kit 99

Aug 03, 2017: Diasorin Group Reports Strong Growth in Revenues and Profitability in Q2 2017 99

Jul 28, 2017: Diasorin Launches 3 New Primer Pairs For Use In Molecular Testing: Pneumocystis Jirovecii, Group C Streptococcus, And Group G Streptococcus 102

Jul 10, 2017: Diasorin Launches IAM CBFB-MYH11, Completing The Diagnostic Test Menu For Molecular Screening Of Acute Myeloid Leukemia By Q-LAMP 103

Appendix 104

Methodology 104

About GlobalData 106

Contact Us 106

Disclaimer 107

List of Figures

DiaSorin S.p.A Pipeline Products by Equipment Type 10

DiaSorin S.p.A Pipeline Products by Development Stage 15

DiaSorin S.p.A Ongoing Clinical Trials by Trial Status 19

List of Tables

DiaSorin S.p.A Pipeline Products and Ongoing Clinical Trials Overview 9

DiaSorin S.p.A Pipeline Products by Equipment Type 10

DiaSorin S.p.A Pipeline Products by Indication 11

DiaSorin S.p.A Ongoing Clinical Trials by Trial Status 11

DiaSorin S.p.A, Key Facts 13

DiaSorin S.p.A, Major Products and Services 14

DiaSorin S.p.A Number of Pipeline Products by Development Stage 15

DiaSorin S.p.A Pipeline Products Summary by Development Stage 16

DiaSorin S.p.A Ongoing Clinical Trials by Trial Status 19

DiaSorin S.p.A Ongoing Clinical Trials Summary 20

BCR-ABL ABL Assay-Product Status 21

BCR-ABL ABL Assay-Product Description 21

BCR-ABL P190 + ABL Assay-Product Status 22

BCR-ABL P190 + ABL Assay-Product Description 22

BCR-ABL v1.5 Assay-Product Status 23

BCR-ABL v1.5 Assay-Product Description 23

C-Kit 816 Assay-Product Status 24

C-Kit 816 Assay-Product Description 24

C-Kit 822 Assay-Product Status 25

C-Kit 822 Assay-Product Description 25

Diagnostic Assay-Atypical Pneumonia-Product Status 26

Diagnostic Assay-Atypical Pneumonia-Product Description 26

Diagnostic Assay-Chronic Kidney Disease-Product Status 27

Diagnostic Assay-Chronic Kidney Disease-Product Description 27

Diagnostic Assay-Enteric Infection-Product Status 28

Diagnostic Assay-Enteric Infection-Product Description 28

Diagnostic Assay-Fecal Occult Blood Assay-Product Status 29

Diagnostic Assay-Fecal Occult Blood Assay-Product Description 29

Diagnostic Assay-GI Inflammation-Product Status 30

Diagnostic Assay-GI Inflammation-Product Description 30

Diagnostic Assay-Group B Streptococcus Infection-Product Status 31

Diagnostic Assay-Group B Streptococcus Infection-Product Description 31

Diagnostic Assay-HBsAg High Throughput-Product Status 32

Diagnostic Assay-HBsAg High Throughput-Product Description 32

Diagnostic Assay-HCV II-Product Status 33

Diagnostic Assay-HCV II-Product Description 33

Diagnostic Assay-HSV M + cntr-Product Status 34

Diagnostic Assay-HSV M + cntr-Product Description 34

Diagnostic Assay-Lactoferrin Assay-Product Status 35

Diagnostic Assay-Lactoferrin Assay-Product Description 35

Diagnostic Assay-Lipase Assay-Product Status 36

Diagnostic Assay-Lipase Assay-Product Description 36

Diagnostic Assay-Mycoplasma Genitalium Infection-Product Status 37

Diagnostic Assay-Mycoplasma Genitalium Infection-Product Description 37

Diagnostic Assay-Streptococcus Pneumonia-Product Status 38

Diagnostic Assay-Streptococcus Pneumonia-Product Description 38

Diagnostic Assay-Vaginosis-Product Status 39

Diagnostic Assay-Vaginosis-Product Description 39

Diagnostic Assay-Vector Borne Diseases-Product Status 40

Diagnostic Assay-Vector Borne Diseases-Product Description 40

Estradiol II Assay-Product Status 41

Estradiol II Assay-Product Description 41

H.Influenza B Assay-Product Status 42

H.Influenza B Assay-Product Description 42

Human Herpes Virus 6 IgG EIA Assay-Product Status 43

Human Herpes Virus 6 IgG EIA Assay-Product Description 43

Human Herpes Virus 8 IgG IFA Assay-Product Status 44

Human Herpes Virus 8 IgG IFA Assay-Product Description 44

Hyperphosphate-High Bone Turnover Assay-Product Status 45

Hyperphosphate-High Bone Turnover Assay-Product Description 45

LAMP CBF-MYH D Assay-Product Status 46

LAMP CBF-MYH D Assay-Product Description 46

LAMP CBF-MYH E Assay-Product Status 47

LAMP CBF-MYH E Assay-Product Description 47

LAMP VCA IgA Assay-Product Status 48

LAMP VCA IgA Assay-Product Description 48

LIAISON-Anti-HDV Assay-Product Status 49

LIAISON-Anti-HDV Assay-Product Description 49

LIAISON-Chlamydia P. IgA Assay-Product Status 50

LIAISON-Chlamydia P. IgA Assay-Product Description 50

LIAISON-Chlamydia P. IgG Assay-Product Status 51

LIAISON-Chlamydia P. IgG Assay-Product Description 51

LIAISON-High Sclerostin Assay-Product Status 52

LIAISON-High Sclerostin Assay-Product Description 52

LIAISON-Hyperphosphate Low Bone Turnover Assay-Product Status 53

LIAISON-Hyperphosphate Low Bone Turnover Assay-Product Description 53

LIAISON-Tg Gen II Assay-Product Status 54

LIAISON-Tg Gen II Assay-Product Description 54

LIAISON IAM-Acute Lymphoblastic Leukemia Test-Product Status 55

LIAISON IAM-Acute Lymphoblastic Leukemia Test-Product Description 55

LIAISON IAM-Acute Promyelocytic Leukemia Test-Product Status 56

LIAISON IAM-Acute Promyelocytic Leukemia Test-Product Description 56

LIAISON IAM-EBV Assay-Product Status 57

LIAISON IAM-EBV Assay-Product Description 57

LIAISON IAM-Myeloproliferative Neoplasm Assay-Product Status 58

LIAISON IAM-Myeloproliferative Neoplasm Assay-Product Description 58

LIAISON XL-Chlamydia Pneumoniae Assay-Product Status 59

LIAISON XL-Chlamydia Pneumoniae Assay-Product Description 59

LIAISON XL-H. Pylori Ag Assay-Product Status 60

LIAISON XL-H. Pylori Ag Assay-Product Description 60

LIAISON XL-H. Pylori Ag Assay-Helicobacter Pylori Sample Collection Protocol Post-therapy 61

LIAISON XL-H. Pylori Ag Assay-Helicobacter Pylori Sample Collection Protocol Pre-therapy 61

LIAISON XL-Hepatitis A Assay-Product Status 62

LIAISON XL-Hepatitis A Assay-Product Description 62

LIAISON XL-Hepatitis B Assay-Product Status 63

LIAISON XL-Hepatitis B Assay-Product Description 63

LIAISON XL-Hepatitis C Assay-Product Status 64

LIAISON XL-Hepatitis C Assay-Product Description 64

Liaison XL-HIV-Product Status 65

Liaison XL-HIV-Product Description 65

LIAISON XL-Parvovirus B19 Test-Product Status 66

LIAISON XL-Parvovirus B19 Test-Product Description 66

LIAISON XL-Sclerostin Assay-Product Status 67

LIAISON XL-Sclerostin Assay-Product Description 67

LIAISON XL Zika Capture IgM Assay-Product Status 68

LIAISON XL Zika Capture IgM Assay-Product Description 68

LIAISON XL- Procalcitonin Assay-Product Status 69

LIAISON XL- Procalcitonin Assay-Product Description 69

LIAISON XS-Product Status 70

LIAISON XS-Product Description 70

Neisseria meningitidis Assay-Product Status 71

Neisseria meningitidis Assay-Product Description 71

Parvovirus B19 IFA Assay-Product Status 72

Parvovirus B19 IFA Assay-Product Description 72

PML-RAR Alpha BCR2 Assay-Product Status 73

PML-RAR Alpha BCR2 Assay-Product Description 73

PML-RAR1 + ABL Assay-Product Status 74

PML-RAR1 + ABL Assay-Product Description 74

PML-RAR2 + ABL Assay-Product Status 75

PML-RAR2 + ABL Assay-Product Description 75

PML-RAR3 + ABL Assay-Product Status 76

PML-RAR3 + ABL Assay-Product Description 76

Progesterone II Assay-Product Status 77

Progesterone II Assay-Product Description 77

Quant ABL Assay-Product Status 78

Quant ABL Assay-Product Description 78

Quant BCR-ABL p210 Assay-Product Status 79

Quant BCR-ABL p210 Assay-Product Description 79

Reagent ASRs-Gastro-intestinal Infections-Product Status 80

Reagent ASRs-Gastro-intestinal Infections-Product Description 80

Reagent ASRs-Genetic Disorders-Product Status 81

Reagent ASRs-Genetic Disorders-Product Description 81

Reagent ASRs-Immuno-Compromised Disorders-Product Status 82

Reagent ASRs-Immuno-Compromised Disorders-Product Description 82

Reagent ASRs-Infectious Disease-Product Status 83

Reagent ASRs-Infectious Disease-Product Description 83

Reagent ASRs-Respiratory Disease-Product Status 84

Reagent ASRs-Respiratory Disease-Product Description 84

Reagent ASRs-Vector-Borne Disease-Product Status 85

Reagent ASRs-Vector-Borne Disease-Product Description 85

Respiratory Virus Panel-Product Status 86

Respiratory Virus Panel-Product Description 86

Simplexa Bordetella Direct-Product Status 87

Simplexa Bordetella Direct-Product Description 87

Simplexa Enterovirus Direct-Product Status 88

Simplexa Enterovirus Direct-Product Description 88

Simplexa MRSA Direct-Product Status 89

Simplexa MRSA Direct-Product Description 89

DiaSorin SpA, Key Employees 91

DiaSorin S.p.A, Key Employee Biographies 92

DiaSorin SpA, Other Locations 93

DiaSorin SpA, Subsidiaries 93

Glossary 105

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Trinity Biotech Plc

Roche Diagnostics SpA

Randox Laboratories Ltd

EKF Diagnostics Holdings Plc

Biohit Oyj

DiaSorin S.p.A, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 53520
Site License
USD 1500 INR 107040
Corporate User License
USD 2250 INR 160560

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com